Cargando…
Diversion colitis and pouchitis: A mini-review
Diversion colitis is characterized by inflammation of the mucosa in the defunctioned segment of the colon after colostomy or ileostomy. Similar to diversion colitis, diversion pouchitis is an inflammatory disorder occurring in the ileal pouch, resulting from the exclusion of the fecal stream and a sub...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922993/ https://www.ncbi.nlm.nih.gov/pubmed/29713128 http://dx.doi.org/10.3748/wjg.v24.i16.1734 |
_version_ | 1783318263873142784 |
---|---|
author | Tominaga, Kentaro Kamimura, Kenya Takahashi, Kazuya Yokoyama, Junji Yamagiwa, Satoshi Terai, Shuji |
author_facet | Tominaga, Kentaro Kamimura, Kenya Takahashi, Kazuya Yokoyama, Junji Yamagiwa, Satoshi Terai, Shuji |
author_sort | Tominaga, Kentaro |
collection | PubMed |
description | Diversion colitis is characterized by inflammation of the mucosa in the defunctioned segment of the colon after colostomy or ileostomy. Similar to diversion colitis, diversion pouchitis is an inflammatory disorder occurring in the ileal pouch, resulting from the exclusion of the fecal stream and a subsequent lack of nutrients from luminal bacteria. Although the vast majority of patients with surgically-diverted gastrointestinal tracts remain asymptomatic, it has been reported that diversion colitis and pouchitis might occur in almost all patients with diversion. Surgical closure of the stoma, with reestablishment of gut continuity, is the only curative intervention available for patients with diversion disease. Pharmacologic treatments using short-chain fatty acids, mesalamine, or corticosteroids are reportedly effective for those who are not candidates for surgical reestablishment; however, there are no established assessment criteria for determining the severity of diversion colitis, and no management strategies to date. Therefore, in this mini-review, we summarize and review various recently-reported treatments for diversion disease. We are hopeful that the information summarized here will assist physicians who treat patients with diversion colitis and pouchitis, leading to better case management. |
format | Online Article Text |
id | pubmed-5922993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-59229932018-04-30 Diversion colitis and pouchitis: A mini-review Tominaga, Kentaro Kamimura, Kenya Takahashi, Kazuya Yokoyama, Junji Yamagiwa, Satoshi Terai, Shuji World J Gastroenterol Minireviews Diversion colitis is characterized by inflammation of the mucosa in the defunctioned segment of the colon after colostomy or ileostomy. Similar to diversion colitis, diversion pouchitis is an inflammatory disorder occurring in the ileal pouch, resulting from the exclusion of the fecal stream and a subsequent lack of nutrients from luminal bacteria. Although the vast majority of patients with surgically-diverted gastrointestinal tracts remain asymptomatic, it has been reported that diversion colitis and pouchitis might occur in almost all patients with diversion. Surgical closure of the stoma, with reestablishment of gut continuity, is the only curative intervention available for patients with diversion disease. Pharmacologic treatments using short-chain fatty acids, mesalamine, or corticosteroids are reportedly effective for those who are not candidates for surgical reestablishment; however, there are no established assessment criteria for determining the severity of diversion colitis, and no management strategies to date. Therefore, in this mini-review, we summarize and review various recently-reported treatments for diversion disease. We are hopeful that the information summarized here will assist physicians who treat patients with diversion colitis and pouchitis, leading to better case management. Baishideng Publishing Group Inc 2018-04-28 2018-04-28 /pmc/articles/PMC5922993/ /pubmed/29713128 http://dx.doi.org/10.3748/wjg.v24.i16.1734 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Tominaga, Kentaro Kamimura, Kenya Takahashi, Kazuya Yokoyama, Junji Yamagiwa, Satoshi Terai, Shuji Diversion colitis and pouchitis: A mini-review |
title | Diversion colitis and pouchitis: A mini-review |
title_full | Diversion colitis and pouchitis: A mini-review |
title_fullStr | Diversion colitis and pouchitis: A mini-review |
title_full_unstemmed | Diversion colitis and pouchitis: A mini-review |
title_short | Diversion colitis and pouchitis: A mini-review |
title_sort | diversion colitis and pouchitis: a mini-review |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922993/ https://www.ncbi.nlm.nih.gov/pubmed/29713128 http://dx.doi.org/10.3748/wjg.v24.i16.1734 |
work_keys_str_mv | AT tominagakentaro diversioncolitisandpouchitisaminireview AT kamimurakenya diversioncolitisandpouchitisaminireview AT takahashikazuya diversioncolitisandpouchitisaminireview AT yokoyamajunji diversioncolitisandpouchitisaminireview AT yamagiwasatoshi diversioncolitisandpouchitisaminireview AT teraishuji diversioncolitisandpouchitisaminireview |